Research and Markets: Greece In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2017

DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/cd205b/greece_in_vitro_di) has announced the addition of Global Markets Direct's new report "Greece In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2017" to their offering.

“Greece In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2017”

Greece In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2017, a new report by Global Markets Direct, provides key market data on the Greece In Vitro Diagnostics market. The report provides value (USD million), for each segment and sub-segment within seven market categories - Clinical Chemistry, Genetic Testing, Haematology, Histology And Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on key recent developments.

Scope

• Market size and company share data for In Vitro Diagnostics market categories - Clinical Chemistry, Genetic Testing, Haematology, Histology And Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture.
• Annualized market revenues (USD million) for each of the segments and sub-segments within seven market categories. Data from 2003 to 2010, forecast forward for 7 years to 2017.
• 2010 company shares and distribution shares data for each of the seven market categories.
• Global corporate-level profiles of key companies operating within the Greece In Vitro Diagnostics market.

Reasons to buy

• Develop business strategies by identifying the key market categories and segments poised for strong growth.
• Develop market-entry and market expansion strategies.
• Design competition strategies by identifying who-stands-where in the Greece In Vitro Diagnostics competitive landscape.

Companies Mentioned:

• F. Hoffmann-La Roche Ltd.
• Siemens Healthcare
• Abbott Laboratories
• Beckman Coulter, Inc.
• Ortho-Clinical Diagnostics Inc.
• Sysmex Corporation
• Bio-Rad Laboratories, Inc.
• Becton, Dickinson and Company
• Phadia AB
• DiaSorin S.p.A
• DIAGNOSTICA STAGO, Inc.
• PerkinElmer, Inc.
• Thermo Fisher Scientific Inc.
• Qiagen N.V.
• Grifols, S.A.
• HORIBA, Ltd.
• Gen-Probe Incorporated
• Immucor, Inc.
• Life Technologies Corporation
• Danaher Corporation
• Hologic, Inc.
• Cellestis Limited

For more information visit http://www.researchandmarkets.com/research/cd205b/greece_in_vitro_di